Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Diseases of the Thyroid

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 140 articles:
HTML format



Single Articles


    December 2020
  1. ELEFTHERIADOU AM, Mehl S, Renko K, Kasim RH, et al
    Re-visiting autoimmunity to sodium-iodide symporter and pendrin in thyroid disease.
    Eur J Endocrinol. 2020;183:571-580.
    PubMed     Abstract available


  2. GIANNETTA E, Guarnotta V, Altieri B, Sciammarella C, et al
    ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus.
    Eur J Endocrinol. 2020;183:R197-R215.
    PubMed     Abstract available


  3. PEETERS RP, Brito JP
    Subclinical hypothyroidism: to treat or not to treat?
    Eur J Endocrinol. 2020;183:D15-D24.
    PubMed     Abstract available


  4. WOOD CL, Cole M, Donaldson M, Dunger DB, et al
    Randomised trial of block and replace vs dose titration thionamide in young people with thyrotoxicosis.
    Eur J Endocrinol. 2020;183:637-645.
    PubMed     Abstract available


  5. NAAFS JC, Verkerk PH, Fliers E, van Trotsenburg ASP, et al
    Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening.
    Eur J Endocrinol. 2020;183:627-636.
    PubMed     Abstract available


  6. HOI-YEE LI G, Cheung CL, Zhao SX, Song HD, et al
    Genome-wide meta-analysis reveals novel susceptibility loci for thyrotoxic periodic paralysis.
    Eur J Endocrinol. 2020;183:607-617.
    PubMed     Abstract available


  7. SANTANA NO, Lerario AM, Schmerling CK, Marui S, et al
    Molecular profile of Hurthle cell carcinomas: recurrent mutations in the Wnt/beta-catenin pathway.
    Eur J Endocrinol. 2020;183:647-656.
    PubMed     Abstract available


    November 2020
  8. DEANDREA M, Trimboli P, Creanza A, Garino F, et al
    Long-term follow-up of cystic thyroid nodules treated with percutaneous ethanol injection (PEI) using two different approaches.
    Eur J Endocrinol. 2020;183:489-495.
    PubMed     Abstract available


    October 2020
  9. GROENWOLD RHH, Dekkers OM
    Missing data: the impact of what is not there.
    Eur J Endocrinol. 2020;183:E7-E9.
    PubMed     Abstract available


  10. VAN WELIE N, Portela M, Dreyer K, Schoonmade LJ, et al
    Iodine contrast prior to or during pregnancy and neonatal thyroid function: a systematic review.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0627.R1. doi: 10.1530/EJE-20-0627.
    PubMed     Abstract available


  11. KIM M, Kim BH, Lee H, Nam H, et al
    Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0686.R1. doi: 10.1530/EJE-20-0686.
    PubMed     Abstract available


  12. JIN H, Lin W, Lu L, Cui M, et al
    Conventional thyroidectomy versus thyroid thermal ablation on postoperative quality of life and satisfaction for patients with benign thyroid nodules.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0562.R1. doi: 10.1530/EJE-20-0562.
    PubMed     Abstract available


  13. ILLOUZ F, Chanson P, Sonnet E, Brue T, et al
    Somatostatin receptor ligands induce TSH deficiency in thyrotropin-secreting pituitary adenoma.
    Eur J Endocrinol. 2020 Oct 1. pii: EJE-20-0484.R2. doi: 10.1530/EJE-20-0484.
    PubMed     Abstract available


    September 2020
  14. ROTONDI M, Groppelli G, Croce L, Latrofa F, et al
    Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up study.
    Eur J Endocrinol. 2020;183:317-323.
    PubMed     Abstract available


    August 2020
  15. SALERNO M, Improda N, Capalbo D
    MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children.
    Eur J Endocrinol. 2020;183:R13-R28.
    PubMed     Abstract available


  16. LONCAR I, Dulfer RR, Massolt ET, Timman R, et al
    Postoperative parathyroid hormone levels as a predictor for persistent hypoparathyroidism.
    Eur J Endocrinol. 2020;183:149-159.
    PubMed     Abstract available


  17. DE VRIES F, Bruin M, Cersosimo A, van Beuzekom CN, et al
    An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria.
    Eur J Endocrinol. 2020;183:141-148.
    PubMed     Abstract available


  18. STOUPA A, Al Hage Chehade G, Kariyawasam D, Tohier C, et al
    First Case of Fetal Goitrous Hypothyroidism Due to SLC5A5/NIS Mutations.
    Eur J Endocrinol. 2020 Aug 1. pii: EJE-20-0255.R2. doi: 10.1530/EJE-20-0255.
    PubMed     Abstract available


  19. MAGRI F, Chytiris S, Croce L, Molteni M, et al
    Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard.
    Eur J Endocrinol. 2020 Aug 1. pii: EJE-20-0682.R1. doi: 10.1530/EJE-20-0682.
    PubMed     Abstract available


    July 2020
  20. LEE J, Kim CH, Min IK, Jeong S, et al
    Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer.
    Eur J Endocrinol. 2020;183:83-93.
    PubMed     Abstract available


  21. LANIA A, Sandri MT, Cellini M, Mirani M, et al
    THYROTOXICOSIS IN PATIENTS WITH COVID-19: THE THYRCOV STUDY.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0335.R2. doi: 10.1530/EJE-20-0335.
    PubMed     Abstract available


  22. LEBBINK CA, Dekker BL, Bocca G, Braat AJ, et al
    New National Recommendations for the Treatment of Pediatric Differentiated Thyroid Carcinoma in the Netherlands.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0191.R1. doi: 10.1530/EJE-20-0191.
    PubMed     Abstract available


  23. TERZOLO M, Puglisi S, Reimondo G, Dimopoulou C, et al
    Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-19-1009.R1. doi: 10.1530/EJE-19-1009.
    PubMed     Abstract available


  24. CAMPOPIANO MC, Podesta D, Bianchi F, Giani C, et al
    No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0088.R2. doi: 10.1530/EJE-20-0088.
    PubMed     Abstract available


    June 2020
  25. VAN SANTEN HM, Alexander EK, Rivkees S, Frey E, et al
    Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors.
    Eur J Endocrinol. 2020 Jun 1. pii: EJE-20-0237.R1. doi: 10.1530/EJE-20-0237.
    PubMed     Abstract available


  26. CASTELLANA M, Grani G, Radzina M, Guerra V, et al
    Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules. A meta-analysis.
    Eur J Endocrinol. 2020 Jun 1. pii: EJE-20-0204.R3. doi: 10.1530/EJE-20-0204.
    PubMed     Abstract available


  27. STROEK K, Heijboer AC, Bouva MJ, van der Ploeg CPB, et al
    Critical evaluation of the newborn screening for congenital hypothyroidism in the Netherlands.
    Eur J Endocrinol. 2020 Jun 1. pii: EJE-19-1048.R2. doi: 10.1530/EJE-19-1048.
    PubMed     Abstract available


    May 2020
  28. SKOV J, Eriksson D, Kuja-Halkola R, Hoijer J, et al
    Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study.
    Eur J Endocrinol. 2020;182:473-480.
    PubMed     Abstract available


  29. VRACHIMIS A, Iacovou I, Giannoula E, Giovanella L, et al
    Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0269.R2. doi: 10.1530/EJE-20-0269.
    PubMed     Abstract available


  30. BOELAERT K, Visser WE, Taylor PN, Moran C, et al
    Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0445.R1. doi: 10.1530/EJE-20-0445.
    PubMed     Abstract available


  31. DE RIDDER M, Nieveen van Dijkum E, Engelsman A, Kapiteijn E, et al
    Anaplastic Thyroid Carcinoma; a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0080.R1. doi: 10.1530/EJE-20-0080.
    PubMed     Abstract available


  32. MORETTI S, Menicali E, Nucci N, Guzzetti M, et al
    THERAPY OF ENDOCRINE DISEASE: Immunotherapy of advanced thyroid cancer: from bench to bedside.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0283.R1. doi: 10.1530/EJE-20-0283.
    PubMed     Abstract available


  33. CLEMENT SC, Lebbink CA, Klein Hesselink MS, Teepen JC, et al
    Presentation and Outcome of Subsequent Thyroid Cancer among Childhood Cancer Survivors Compared to Sporadic Thyroid Cancer; a Matched National Study.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0153.R1. doi: 10.1530/EJE-20-0153.
    PubMed     Abstract available


    March 2020
  34. LAMARTINA L, Handkiewicz-Junak D
    Follow-up of low risk thyroid cancer patients: can we stop follow up after 5 years of complete remission?
    Eur J Endocrinol. 2020 Mar 1. pii: EJE-19-0960.R1. doi: 10.1530/EJE-19-0960.
    PubMed     Abstract available


  35. KHOO S, Lyons G, McGowan A, Gurnell M, et al
    FAMILIAL DYSALBUMINAEMIC HYPERTHYROXINEMIA INTERFERES WITH CURRENT FREE THYROID HORMONE IMMUNOASSAY METHODS.
    Eur J Endocrinol. 2020 Mar 1. pii: EJE-19-1021.R1. doi: 10.1530/EJE-19-1021.
    PubMed     Abstract available


    February 2020
  36. WILDING JP
    Endocrine testing in obesity.
    Eur J Endocrinol. 2020 Feb 1. pii: EJE-20-0099. doi: 10.1530/EJE-20-0099.
    PubMed     Abstract available


    January 2020
  37. PASQUALI R, Casanueva F, Haluzik M, van Hulsteijn L, et al
    European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
    Eur J Endocrinol. 2020;182:G1-G32.
    PubMed     Abstract available


  38. NAAFS JC, Vendrig LM, Limpens J, van der Lee JH, et al
    Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data.
    Eur J Endocrinol. 2020 Jan 1. pii: EJE-19-0874.R2. doi: 10.1530/EJE-19-0874.
    PubMed     Abstract available


  39. PEPE G, Corica D, de Sanctis L, Salerno M, et al
    Prospective evaluation of autoimmune and non-autoimmune subclinical hypothyroidism in Down syndrome children.
    Eur J Endocrinol. 2020 Jan 1. pii: EJE-19-0823.R2. doi: 10.1530/EJE-19-0823.
    PubMed     Abstract available


  40. VAN HULSTEIJN LT, Pasquali R, Casanueva F, Haluzik M, et al
    Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis.
    Eur J Endocrinol. 2020;182:11-21.
    PubMed     Abstract available


    December 2019
  41. MIRALLIE E, Borel F, Tresallet C, Hamy A, et al
    Impact of total thyroidectomy on quality of life at 6 months: the prospective ThyrQoL multicentre trial.
    Eur J Endocrinol. 2019 Dec 1. pii: EJE-19-0587.R3. doi: 10.1530/EJE-19-0587.
    PubMed     Abstract available


    November 2019
  42. DAI D, Tan Y, Guo L, Tang A, et al
    Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing.
    Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0524.R1. doi: 10.1530/EJE-19-0524.
    PubMed     Abstract available


  43. KIM KJ, Jang S, Kim KJ, An JH, et al
    Actual Causes of Death in Thyroid Cancer Patients in Korea: A Nationwide Case Control Cohort Study.
    Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0548.R1. doi: 10.1530/EJE-19-0548.
    PubMed     Abstract available


  44. AYDEMIRLI MD, Kapiteijn E, Ferrier KRM, Ottevanger N, et al
    Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data.
    Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0763.R1. doi: 10.1530/EJE-19-0763.
    PubMed     Abstract available


    October 2019
  45. BAI X, Chen X, Wu X, Huang Y, et al
    Immune checkpoint inhibitor-associated thyroid dysfunction: a disproportionality analysis using the WHO adverse drug reaction database VigiBase.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0535.R2. doi: 10.1530/EJE-19-0535.
    PubMed     Abstract available


  46. VAN VELSEN EFS, Massolt E, Heersema H, Kam BLR, et al
    Longitudinal Analysis of Quality of Life in Patients Treated for Differentiated Thyroid Cancer.
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0550.R2. doi: 10.1530/EJE-19-0550.
    PubMed     Abstract available


    September 2019
  47. GUAN H, Morais NAOES, Stuart J, Ahmadi S, et al
    Discordance of Serological and Sonographic Markers for Hashimoto's Thyroiditis with Gold Standard Histopathology.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0424.R2. doi: 10.1530/EJE-19-0424.
    PubMed     Abstract available


  48. CAMPI I, Perego GB, Ravogli A, Groppelli A, et al
    Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0515.R1. doi: 10.1530/EJE-19-0515.
    PubMed     Abstract available


  49. KOWALSKA A
    "Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspicious for malignancy or malignant fine-needle aspiration cytology findings:
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0651. doi: 10.1530/EJE-19-0651.
    PubMed     Abstract available


    August 2019
  50. QICHANG W, Lin B, Gege Z, Youjia Z, et al
    Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis.
    Eur J Endocrinol. 2019;181:93-102.
    PubMed     Abstract available


    July 2019
  51. BONGIOVANNI M, Faquin W, Giovanella L, Durante C, et al
    Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspicious for malignancy or malignant fine-needle aspiration cytology findings:
    Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0223.R1. doi: 10.1530/EJE-19-0223.
    PubMed     Abstract available


  52. SMITH TJ, Bartalena L
    Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?
    Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0389.R1. doi: 10.1530/EJE-19-0389.
    PubMed     Abstract available


    June 2019
  53. WANG B, He W, Li Q, Jia X, et al
    U-shaped relationship between iodine status and thyroid autoimmunity risk in adults.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0212.R1. doi: 10.1530/EJE-19-0212.
    PubMed     Abstract available


  54. GIOVANELLA L, Duntas LH
    MANAGEMENT OF ENDOCRINE DISEASE: The Role of rhTSH in the Management of Differentiated Thyroid Cancer: Pros and Cons.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0149.R2. doi: 10.1530/EJE-19-0149.
    PubMed     Abstract available


    May 2019
  55. TWITO O, Grozinsky-Glasberg S, Levy S, Bachar G, et al
    Clinico-pathological and Dynamic Prognostic Factors in Sporadic and Familial Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Eur J Endocrinol. 2019 May 1. pii: EJE-18-1008.R1. doi: 10.1530/EJE-18-1008.
    PubMed     Abstract available


  56. LEE WK, Lee J, Kim H, Lee SG, et al
    Peripheral location and infiltrative margin predict invasive features of papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2019 May 1. pii: EJE-18-1025.R1. doi: 10.1530/EJE-18-1025.
    PubMed     Abstract available


  57. EFFRAIMIDIS G
    MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in Autoimmune Thyroid Disease. Are they useful?
    Eur J Endocrinol. 2019 May 1. pii: EJE-19-0234.R1. doi: 10.1530/EJE-19-0234.
    PubMed     Abstract available


    April 2019
  58. TSENG CH
    Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0133.R1. doi: 10.1530/EJE-19-0133.
    PubMed     Abstract available


  59. CENSI S, Barollo S, Grespan E, Watutantrige-Fernando S, et al
    PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0073.R2. doi: 10.1530/EJE-19-0073.
    PubMed     Abstract available


  60. LILLEVANG-JOHANSEN M, Abrahamsen B, Jorgensen H, Brix TH, et al
    Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0006.R1. doi: 10.1530/EJE-19-0006.
    PubMed     Abstract available


    March 2019
  61. ROTONDI M, Carbone A, Coperchini F, Fonte R, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: IgG4-related thyroid autoimmune disease.
    Eur J Endocrinol. 2019 Mar 1. pii: EJE-18-1024.R1. doi: 10.1530/EJE-18-1024.
    PubMed     Abstract available


    January 2019
  62. VAN DER TUIN K, Ventayol M, Corver W, Khalifa M, et al
    Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma.
    Eur J Endocrinol. 2019 Jan 1. pii: EJE-18-0653.R1. doi: 10.1530/EJE-18-0653.
    PubMed     Abstract available


    December 2018
  63. ZHANG L, Castellana M, Virili C, Crescenzi A, et al
    Fine-needle aspiration to diagnose primary thyroid lymphoma: a systematic review and meta-analysis.
    Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0672.R1. doi: 10.1530/EJE-18-0672.
    PubMed     Abstract available


    November 2018
  64. DEANDREA M, Garino F, Mormile A, Garberoglio R, et al
    Radiofrequency ablation for benign thyroid nodules according to different US features: an Italian multicentre prospective study.
    Eur J Endocrinol. 2018 Nov 1. pii: EJE-18-0685.R1. doi: 10.1530/EJE-18-0685.
    PubMed     Abstract available


    October 2018
  65. BURCH HB, Cooper DS
    ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later
    Eur J Endocrinol. 2018;179:R261-R274.
    PubMed     Abstract available


  66. IGLESIAS FELIP C, Zafon C, Temprana-Salvador J, Garcia-Burillo A, et al
    ONE-STEP NUCLEIC ACID AMPLIFICATION FOR INTRAOPERATIVE ANALYSIS OF SENTINEL LYMPH NODE IN PAPILLARY THYROID CARCINOMA.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0624.R1. doi: 10.1530/EJE-18-0624.
    PubMed     Abstract available


  67. SUH B, Shin DW, Park Y, Lim H, et al
    Increased Cardiovascular Risk in Thyroid Cancer Patients Taking Levothyroxine: a Nationwide Cohort Study in Korea.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0551.R1. doi: 10.1530/EJE-18-0551.
    PubMed     Abstract available


    September 2018
  68. PETERS C, van Trotsenburg ASP, Schoenmakers N
    DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
    Eur J Endocrinol. 2018 Sep 24. pii: EJE-18-0383. doi: 10.1530/EJE-18-0383.
    PubMed     Abstract available


    July 2018
  69. CHAIGNEAU E, Russ G, Royer B, Bigorgne C, et al
    TIRADS score is of limited clinical value for risk stratification of indeterminate cytological results.
    Eur J Endocrinol. 2018;179:13-20.
    PubMed     Abstract available


    June 2018
  70. DEMARTINO L, McMahon R, Caggana M, Tavakoli NP, et al
    Gender disparities in screening for congenital hypothyroidism using thyroxine as a primary screen.
    Eur J Endocrinol. 2018 Jun 26. pii: EJE-18-0399. doi: 10.1530/EJE-18-0399.
    PubMed     Abstract available


  71. ALBANO D, Bertagna F, Bonacina M, Durmo R, et al
    Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
    Eur J Endocrinol. 2018 Jun 13. pii: EJE-18-0253. doi: 10.1530/EJE-18-0253.
    PubMed     Abstract available


  72. SONG E, Jeon MJ, Oh HS, Han M, et al
    Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary thyroid carcinoma?
    Eur J Endocrinol. 2018 Jun 6. pii: EJE-17-0991. doi: 10.1530/EJE-17-0991.
    PubMed     Abstract available


    May 2018
  73. HEINEN CA, Zhang Z, Klieverik LP, de Wit TC, et al
    Effects of Intravenous Thyrotropin Releasing Hormone on 18F-Fluorodeoxyglucose Uptake in Human Brown Adipose Tissue: A Randomized Controlled Trial.
    Eur J Endocrinol. 2018 May 3. pii: EJE-17-0966. doi: 10.1530/EJE-17-0966.
    PubMed     Abstract available


    April 2018
  74. WIERSINGA WM, Zarkovic M, Bartalena L, Donati S, et al
    PREDICTIVE SCORE FOR THE DEVELOPMENT OR PROGRESSION OF GRAVES' ORBITOPATHY IN PATIENTS WITH NEWLY DIAGNOSED GRAVES' HYPERTHYROIDISM.
    Eur J Endocrinol. 2018 Apr 12. pii: EJE-18-0039. doi: 10.1530/EJE-18-0039.
    PubMed     Abstract available


  75. SUN F, Zhang JX, Yang CY, Gao GQ, et al
    The Genetic Characteristics of Congenital Hypothyroidism in China by Comprehensive Screening of 21 Candidate Genes.
    Eur J Endocrinol. 2018 Apr 12. pii: EJE-17-1017. doi: 10.1530/EJE-17-1017.
    PubMed     Abstract available


  76. LAURIA A, Maddaloni E, Briganti SI, Beretta Anguissola G, et al
    Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules.
    Eur J Endocrinol. 2018 Apr 6. pii: EJE-18-0083. doi: 10.1530/EJE-18-0083.
    PubMed     Abstract available


    March 2018
  77. ROTONDI M, Capelli V, Coperchini F, Pinto S, et al
    Post partum and non-post partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs.
    Eur J Endocrinol. 2018 Mar 20. pii: EJE-17-1063. doi: 10.1530/EJE-17-1063.
    PubMed     Abstract available


  78. LEGER J, Forhan A, Dos Santos S, Larroque B, et al
    Developmental milestones at one year for the offspring of mothers with congenital hypothyroidism: a population-based study.
    Eur J Endocrinol. 2018 Mar 2. pii: EJE-17-0855. doi: 10.1530/EJE-17-0855.
    PubMed     Abstract available


    February 2018
  79. CARVALHO GA, Paz-Filho G, Mesa Junior CO, Graf H, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults.
    Eur J Endocrinol. 2018 Feb 28. pii: EJE-17-0947. doi: 10.1530/EJE-17-0947.
    PubMed     Abstract available


  80. SCOTT ES, Long GV, Guminski A, Clifton-Bligh RJ, et al
    The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Eur J Endocrinol. 2018;178:175-182.
    PubMed     Abstract available


  81. GIELDON L, Masjkur JR, Richter S, Darr R, et al
    Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1.
    Eur J Endocrinol. 2018;178:K1-K9.
    PubMed     Abstract available


    January 2018
  82. GIOVANELLA L, Imperiali M, Verburg FA, Trimboli P, et al
    Early post-treatment risk stratification of differentiated thyroid cancer: comparison of three high-sensitive Tg assays.
    Eur J Endocrinol. 2018;178:77-84.
    PubMed     Abstract available


    December 2017
  83. NIES M, Dekker BL, Sulkers E, Huizinga GA, et al
    Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study.
    Eur J Endocrinol. 2017 Dec 18. pii: EJE-17-0741. doi: 10.1530/EJE-17-0741.
    PubMed     Abstract available


  84. WIERSINGA WM
    THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
    Eur J Endocrinol. 2017;177:R287-R296.
    PubMed     Abstract available


    November 2017
  85. APELLANIZ-RUIZ M, de Kock L, Sabbaghian N, Guaraldi F, et al
    Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame DICER1 deletion.
    Eur J Endocrinol. 2017 Nov 29. pii: EJE-17-0904. doi: 10.1530/EJE-17-0904.
    PubMed     Abstract available


  86. VELTRI F, Kleynen P, Grabczan L, Salajan A, et al
    Pregnancy outcomes are not altered by variation in thyroid function within the normal range in women free of thyroid disease.
    Eur J Endocrinol. 2017 Nov 29. pii: EJE-17-0628. doi: 10.1530/EJE-17-0628.
    PubMed     Abstract available


  87. FETENE DM, Betts KS, Alati R
    MECHANISMS IN ENDOCRINOLOGY: Maternal thyroid dysfunction during pregnancy and behavioural and psychiatric disorders of children: a systematic review.
    Eur J Endocrinol. 2017;177:R261-R273.
    PubMed     Abstract available


  88. ABE K, Narumi S, Suwanai AS, Adachi M, et al
    Association between monoallelic TSHR mutations and congenital hypothyroidism: a Statistical approach.
    Eur J Endocrinol. 2017 Nov 1. pii: EJE-16-1049. doi: 10.1530/EJE-16-1049.
    PubMed     Abstract available


    October 2017
  89. VELASCO II, Taylor PN
    DEBATE: IDENTIFYING AND TREATING SUBCLINICAL THYROID DYSFUNCTION IN PREGNANCY: EMERGING CONTROVERSIES.
    Eur J Endocrinol. 2017 Oct 25. pii: EJE-17-0598. doi: 10.1530/EJE-17-0598.
    PubMed     Abstract available


  90. VILLARROYA-MARQUINA I, Sancho J, Lorente-Poch L, Gallego-Otaegui L, et al
    TIME TO PARATHYROID FUNCTION RECOVERY IN PATIENTS WITH PROTRACTED HYPOPARATHYROIDISM AFTER TOTAL THYROIDECTOMY.
    Eur J Endocrinol. 2017 Oct 24. pii: EJE-17-0589. doi: 10.1530/EJE-17-0589.
    PubMed     Abstract available


  91. BASTOS AU, de Jesus AC, Cerutti JM
    ETV6-NTRK3 and STRN-ALK kinases fusions are recurrent events in papillary thyroid cancer of adult population.
    Eur J Endocrinol. 2017 Oct 18. pii: EJE-17-0499. doi: 10.1530/EJE-17-0499.
    PubMed     Abstract available


    September 2017
  92. SONG YS, Lim JA, Min HS, Kim MJ, et al
    Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
    Eur J Endocrinol. 2017 Sep 1. pii: EJE-17-0456. doi: 10.1530/EJE-17-0456.
    PubMed     Abstract available


    August 2017
  93. HAGLUND F, Hallstrom B, Nilsson IL, HOOg A, et al
    Inflammatory Infiltrates in Parathyroid Tumors.
    Eur J Endocrinol. 2017 Aug 30. pii: EJE-17-0277. doi: 10.1530/EJE-17-0277.
    PubMed     Abstract available


    July 2017
  94. KHAN SR, Bano A, Wakkee M, Korevaar T, et al
    The Association of Autoimmune Thyroid Disease (AITD) with Psoriatic Disease: a prospective cohort study, systematic review and meta-analysis.
    Eur J Endocrinol. 2017 Jul 26. pii: EJE-17-0397. doi: 10.1530/EJE-17-0397.
    PubMed     Abstract available


  95. BARJAKTAROVIC M, Korevaar T, Gaillard R, de Rijke YB, et al
    Childhood thyroid function, body composition and cardiovascular function.
    Eur J Endocrinol. 2017 Jul 19. pii: EJE-17-0369. doi: 10.1530/EJE-17-0369.
    PubMed     Abstract available


  96. LAIN S, Trumpff C, Grosse SD, Olivieri A, et al
    Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted? A debate.
    Eur J Endocrinol. 2017 Jul 10. pii: EJE-17-0107. doi: 10.1530/EJE-17-0107.
    PubMed     Abstract available


  97. CAPDEVILA J, Trigo JM, Aller J, Manzano JL, et al
    Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
    Eur J Endocrinol. 2017 Jul 7. pii: EJE-17-0243. doi: 10.1530/EJE-17-0243.
    PubMed     Abstract available


  98. CHAN YX, Knuiman M, Divitini ML, Brown SJ, et al
    Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Eur J Endocrinol. 2017 Jul 6. pii: EJE-17-0197. doi: 10.1530/EJE-17-0197.
    PubMed     Abstract available


    June 2017
  99. BADZIONG J, Ting S, Synoracki S, Tiedje V, et al
    Differential Regulation of Monocarboxylate Transporter 8 Expression in Thyroid Cancer and Hyperthyroidism.
    Eur J Endocrinol. 2017 Jun 2. pii: EJE-17-0279. doi: 10.1530/EJE-17-0279.
    PubMed     Abstract available


  100. ALBUQUERQUE EV, Scalco RC, Jorge AA
    MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature.
    Eur J Endocrinol. 2017;176:R339-R353.
    PubMed     Abstract available


  101. DIAMANTI-KANDARAKIS E, Dattilo M, Macut D, Duntas L, et al
    MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
    Eur J Endocrinol. 2017;176:R283-R308.
    PubMed     Abstract available


  102. SCHWENSEN CF, Brandt F, Hegedus L, Brix TH, et al
    Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity: a nationwide Danish register study.
    Eur J Endocrinol. 2017;176:669-676.
    PubMed     Abstract available


    May 2017
  103. RUGGERI RM, Trimarchi F, Biondi B
    MANAGEMENT OF ENDOCRINE DISEASE: L- THYROXINE REPLACEMENT THERAPY IN THE FRAIL ELDERLY: A CHALLENGE IN CLINICAL PRACTICE.
    Eur J Endocrinol. 2017 May 31. pii: EJE-17-0321. doi: 10.1530/EJE-17-0321.
    PubMed     Abstract available


  104. VUONG HG, Kondo T, Duong UNP, Pham TQ, et al
    PROGNOSTIC IMPACT OF VASCULAR INVASION IN DIFFERENTIATED THYROID CARCINOMA - A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Eur J Endocrinol. 2017 May 31. pii: EJE-17-0260. doi: 10.1530/EJE-17-0260.
    PubMed     Abstract available


  105. PANI F, Massidda M, Pusceddu V, Puzzoni M, et al
    REGORAFENIB-INDUCED HYPOTHYROIDISM AND CANCER RELATED-FATIGUE: IS THERE A POTENTIAL LINK?
    Eur J Endocrinol. 2017 May 3. pii: EJE-17-0231. doi: 10.1530/EJE-17-0231.
    PubMed     Abstract available


  106. BLIDDAL S, Boas M, Hilsted L, Friis-Hansen L, et al
    Increase in thyroglobulin antibody and thyroid peroxidase antibody levels, but not preterm birth-rate, in pregnant Danish women upon iodine fortification.
    Eur J Endocrinol. 2017;176:603-612.
    PubMed     Abstract available


    April 2017
  107. JEON MJ, Kim WG, Kwon H, Kim M, et al
    Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2017 Apr 21. pii: EJE-17-0160. doi: 10.1530/EJE-17-0160.
    PubMed     Abstract available


  108. BENJAMENS S, Dullaart RPF, Sluiter WJ, Rienstra M, et al
    The Clinical Value of Regular Thyroid Function Tests During Amiodarone Treatment.
    Eur J Endocrinol. 2017 Apr 19. pii: EJE-17-0018. doi: 10.1530/EJE-17-0018.
    PubMed     Abstract available


  109. LEGER J, Carel JC
    MANAGEMENT OF ENDOCRINE DISEASE: Arguments for the prolonged use of antithyroid drugs in children with Graves' disease.
    Eur J Endocrinol. 2017 Apr 5. pii: EJE-16-0938. doi: 10.1530/EJE-16-0938.
    PubMed     Abstract available


  110. ANDERSEN SL, Carle A, Karmisholt JS, Pedersen IB, et al
    MECHANISMS IN ENDOCRINOLOGY: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction. Evidence of fetal programming?
    Eur J Endocrinol. 2017 Apr 4. pii: EJE-16-0947. doi: 10.1530/EJE-16-0947.
    PubMed     Abstract available


  111. KOREVAAR TI, Peeters RP
    The potential benefit of levothyroxine treatment during pregnancy: another step forward.
    Eur J Endocrinol. 2017;176:C3-C5.
    PubMed    


  112. VUONG HG, Kondo T, Pham TQ, Oishi N, et al
    Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
    Eur J Endocrinol. 2017;176:431-439.
    PubMed     Abstract available


  113. ROMERO-KUSABARA IL, Filho JV, Scalissi NM, Melo KC, et al
    Distinct inflammatory gene expression in extraocular muscle and fat from patients with Graves' orbitopathy.
    Eur J Endocrinol. 2017;176:481-488.
    PubMed     Abstract available


    March 2017
  114. CARLE A, Andersen SL, Boelaert K, Laurberg P, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Subclinical Thyrotoxicosis: Prevalence, Causes and Choice of Therapy.
    Eur J Endocrinol. 2017 Mar 8. pii: EJE-16-0276. doi: 10.1530/EJE-16-0276.
    PubMed     Abstract available


    February 2017
  115. LIU J, Sun W, Dong W, Wang Z, et al
    Risk factors for post-thyroidectomy hemorrhage: a meta- analysis.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0757. doi: 10.1530/EJE-16-0757.
    PubMed     Abstract available


  116. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Abstract available


  117. RUGGERI RM, Trimarchi F, Giuffrida G, Certo R, et al
    Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence.
    Eur J Endocrinol. 2017;176:133-141.
    PubMed     Abstract available


  118. STAN MN, Salvi M
    MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials.
    Eur J Endocrinol. 2017;176:R101-R109.
    PubMed     Abstract available


    January 2017
  119. TRIMBOLI P, Zilioli V, Imperiali M, Ceriani L, et al
    High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low to intermediate risk differentiated thyroid carcinomas.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-1011. doi: 10.1530/EJE-16-1011.
    PubMed     Abstract available


  120. KIM N, Gu JY, Yoo HJ, Han SE, et al
    Contact system activation and high thrombin generation in hyperthyroidism.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0835. doi: 10.1530/EJE-16-0835.
    PubMed     Abstract available


  121. ZWAVELING-SOONAWALA N, Witteveen E, Marchal JP, Klouwer F, et al
    Early thyroxine treatment in Down syndrome and thyroid function later in life.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0858. doi: 10.1530/EJE-16-0858.
    PubMed     Abstract available


  122. GROZINSKY-GLASBERG S, Bloom A, Lev-Cohain N, Klimov A, et al
    The Role of Hepatic Trans-Arterial Chemoembolization in Metastatic Medullary Thyroid Carcinoma: A Specialist Center Experience and Review of the Literature.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0960. doi: 10.1530/EJE-16-0960.
    PubMed     Abstract available


  123. STRUJA T, Kaeslin M, Boesiger F, Jutzi R, et al
    External validation of the GREAT score to predict relapse risk in Graves' disease Results from a multicenter, retrospective study with 741 patients.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0986. doi: 10.1530/EJE-16-0986.
    PubMed     Abstract available


  124. KWON H, Jeon MJ, Kim WG, Park S, et al
    A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study.
    Eur J Endocrinol. 2017 Jan 15. pii: EJE-16-0845. doi: 10.1530/EJE-16-0845.
    PubMed     Abstract available


  125. DOSIOU C, Medici M
    MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns.
    Eur J Endocrinol. 2017;176:R21-R38.
    PubMed     Abstract available


    December 2016
  126. PERGIALIOTIS V, Konstantopoulos P, Prodromidou A, Florou V, et al
    MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Dec 22. pii: EJE-16-0611. doi: 10.1530/EJE-16-0611.
    PubMed     Abstract available


  127. WELSH KJ, Soldin SJ
    DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
    Eur J Endocrinol. 2016;175:R255-R263.
    PubMed     Abstract available


  128. CHAKER L, Sedaghat S, Hoorn EJ, Elzen WP, et al
    The association of thyroid function and the risk of kidney function decline: a population-based cohort study.
    Eur J Endocrinol. 2016;175:653-660.
    PubMed     Abstract available


  129. WENDLER J, Kroiss M, Gast K, Kreissl MC, et al
    Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Eur J Endocrinol. 2016;175:521-529.
    PubMed     Abstract available


    November 2016
  130. NAZARPOUR S, Ramezani Tehrani F, Simbar M, Tohidi M, et al
    Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease.
    Eur J Endocrinol. 2016 Nov 22. pii: EJE-16-0548.
    PubMed     Abstract available


  131. RIESCO-EIZAGUIRRE G, Santisteban P
    ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome.
    Eur J Endocrinol. 2016;175:R203-17.
    PubMed     Abstract available


    October 2016
  132. STRUJA T, Fehlberg H, Kutz A, Guebelin L, et al
    Can we predict relapse in Graves' disease? Results from a Systematic Review and Meta-analysis.
    Eur J Endocrinol. 2016 Oct 25. pii: EJE-16-0725.
    PubMed     Abstract available


  133. AKIROV A, Gimbel H, Grossman A, Shochat T, et al
    Elevated TSH in adults treated for hypothyroidism is associated with increased mortality.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0708.
    PubMed     Abstract available


  134. BOAVENTURA P, Batista R, Pestana A, Reis M, et al
    TERT promoter mutations: A genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0740.
    PubMed     Abstract available


  135. DEKKERS OM, Erzsebet Horvath-Puho E, Cannegieter SC, Vandenbroucke J, et al
    Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: population-based cohort study.
    Eur J Endocrinol. 2016 Oct 3. pii: EJE-16-0576.
    PubMed     Abstract available


  136. BOGUSZEWSKI CL, Ayuk J
    MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited.
    Eur J Endocrinol. 2016;175:R147-56.
    PubMed     Abstract available


    September 2016
  137. BRUSCA N, Virili C, Cellini M, Capriello S, et al
    EARLY DETECTION OF BIOCHEMICALLY OCCULT AUTONOMOUS THYROID NODULES.
    Eur J Endocrinol. 2016 Sep 19. pii: EJE-16-0568.
    PubMed     Abstract available


  138. DONOVAN P, McLeod D, Little R, Gordon L, et al
    Cost-Utility Analysis Comparing Radioactive Iodine, Antithyroid Drugs and Total Thyroidectomy for Primary Treatment of Graves' Disease.
    Eur J Endocrinol. 2016 Sep 15. pii: EJE-16-0527.
    PubMed     Abstract available


  139. CAMPI I, Vannucchi G, Salvi M
    THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.
    Eur J Endocrinol. 2016;175:R117-33.
    PubMed     Abstract available


    July 2016
  140. ROUCHER-BOULEZ F, Mallet-Motak D, Samara-Boustani D, Jilani H, et al
    NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.
    Eur J Endocrinol. 2016;175:73-84.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: